Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,610 | Dovepress* | 6,934+ | 673 | 7,607 | |
| PubMed Central* | 676 | 259 | 935 | ||
| Totals | 7,610 | 932 | 8,542 | ||
| *Since 3 December 2019 | |||||
View citations on PubMed Central and Google Scholar